Mariusz Wojciuk1, Mariusz Ciolkiewicz2, Anna Kuryliszyn-Moskal2, Sylwia Chwiesko-Minarowska2, Emilia Sawicka3,4, Katarzyna Ptaszynska-Kopczynska4, Karol Kaminski3. 1. Department of Rehabilitation, Medical University of Bialystok, ul. Sklodowska-Curie 24A, 15-089, Bialystok, Poland. mariusz.wojciuk@umb.edu.pl. 2. Department of Rehabilitation, Medical University of Bialystok, ul. Sklodowska-Curie 24A, 15-089, Bialystok, Poland. 3. Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, Bialystok, Poland. 4. Department of Cardiology, Medical University of Bialystok, Bialystok, Poland.
Abstract
BACKGROUND: Rehabilitation plays an important role in the management of patients with pulmonary arterial hypertension (PAH) and current guidelines recommend implementation of a monitored individualized exercise training program as adjuvant therapy for stable PAH patients on optimal medical treatment. An optimal rehabilitation model for this group of patients has not yet been established. This randomized prospective study assessed the effectiveness and safety of a 6-month home-based caregiver-supervised rehabilitation program among patients with pulmonary arterial hypertension. METHODS: A total of 39 patients with PAH were divided into two groups: intervention group (16 patients), subjected to a 6-month home-based physical training and respiratory rehabilitation program adapted to the clinical status of participants, and control group (23 patients) who did not perform physical training. The 6-min walk test (6MWT), measurement of respiratory muscle strength, quality of life assessment (SF-36, Fatigue Severity Scale - FSS) were performed before study commencement, and after 6 and 12 months. Adherence to exercise protocol and occurrence of adverse events were also assessed. RESULTS:Physical training significantly improved 6MWT distance (by 71.38 ± 83.4 m after 6 months (p = 0.004), which remained increased after 12 months (p = 0.043), and respiratory muscle strength after 6 and 12 months (p < 0.01). Significant improvement in quality of life was observed after the training period with the use of the SF-36 questionnaire (Physical Functioning, p < 0.001; Role Physical, p = 0.015; Vitality, p = 0.022; Role Emotional, p = 0.029; Physical Component Summary, p = 0.005), but it did not persist after study completion. Adherence to exercise protocol was on average 91.88 ± 14.1%. No serious adverse events were noted. CONCLUSION: According to study results, the home-based rehabilitation program dedicated to PAH patients is safe and effective. It improves functional parameters and quality of life. Strength of respiratory muscles and 6MWD remain increased 6 months after training cessation. TRIAL REGISTRATION: ClinicalTrials.gov , NCT03780803 . Registered 12 December 2018.
RCT Entities:
BACKGROUND: Rehabilitation plays an important role in the management of patients with pulmonary arterial hypertension (PAH) and current guidelines recommend implementation of a monitored individualized exercise training program as adjuvant therapy for stable PAH patients on optimal medical treatment. An optimal rehabilitation model for this group of patients has not yet been established. This randomized prospective study assessed the effectiveness and safety of a 6-month home-based caregiver-supervised rehabilitation program among patients with pulmonary arterial hypertension. METHODS: A total of 39 patients with PAH were divided into two groups: intervention group (16 patients), subjected to a 6-month home-based physical training and respiratory rehabilitation program adapted to the clinical status of participants, and control group (23 patients) who did not perform physical training. The 6-min walk test (6MWT), measurement of respiratory muscle strength, quality of life assessment (SF-36, Fatigue Severity Scale - FSS) were performed before study commencement, and after 6 and 12 months. Adherence to exercise protocol and occurrence of adverse events were also assessed. RESULTS: Physical training significantly improved 6MWT distance (by 71.38 ± 83.4 m after 6 months (p = 0.004), which remained increased after 12 months (p = 0.043), and respiratory muscle strength after 6 and 12 months (p < 0.01). Significant improvement in quality of life was observed after the training period with the use of the SF-36 questionnaire (Physical Functioning, p < 0.001; Role Physical, p = 0.015; Vitality, p = 0.022; Role Emotional, p = 0.029; Physical Component Summary, p = 0.005), but it did not persist after study completion. Adherence to exercise protocol was on average 91.88 ± 14.1%. No serious adverse events were noted. CONCLUSION: According to study results, the home-based rehabilitation program dedicated to PAH patients is safe and effective. It improves functional parameters and quality of life. Strength of respiratory muscles and 6MWD remain increased 6 months after training cessation. TRIAL REGISTRATION: ClinicalTrials.gov , NCT03780803 . Registered 12 December 2018.
Authors: Ekkehard Grünig; Christina Eichstaedt; Joan-Albert Barberà; Nicola Benjamin; Isabel Blanco; Eduardo Bossone; Antonio Cittadini; Gerry Coghlan; Paul Corris; Michele D'Alto; Antonello D'Andrea; Marion Delcroix; Frances de Man; Sean Gaine; Stefano Ghio; Simon Gibbs; Lina Gumbiene; Luke S Howard; Martin Johnson; Elena Jurevičienė; David G Kiely; Gabor Kovacs; Alison MacKenzie; Alberto M Marra; Noel McCaffrey; Paul McCaughey; Robert Naeije; Horst Olschewski; Joanna Pepke-Zaba; Abílio Reis; Mário Santos; Stéphanie Saxer; Robert M Tulloh; Silvia Ulrich; Anton Vonk Noordegraaf; Andrew J Peacock Journal: Eur Respir J Date: 2019-02-28 Impact factor: 16.671
Authors: Christina A Eichstaedt; Nicola Benjamin; Panagiota Xanthouli; Alberto M Marra; Ekkehard Grünig Journal: Curr Opin Pulm Med Date: 2019-09 Impact factor: 3.155
Authors: Raymond L Benza; Mardi Gomberg-Maitland; C Greg Elliott; Harrison W Farber; Aimee J Foreman; Adaani E Frost; Michael D McGoon; David J Pasta; Mona Selej; Charles D Burger; Robert P Frantz Journal: Chest Date: 2019-02-14 Impact factor: 9.410
Authors: Thomas Koudstaal; Monique Wapenaar; Dirk van Ranst; Ruud Beesems; Leon van den Toorn; Annemien van den Bosch; Prewesh Chandoesing; Karin Boomars Journal: J Cardiopulm Rehabil Prev Date: 2019-11 Impact factor: 2.081
Authors: Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper Journal: Eur Heart J Date: 2015-08-29 Impact factor: 29.983
Authors: Bonnie B Dean; Vishal Saundankar; Dana Stafkey-Mailey; Rebekah H Anguiano; Andrew C Nelsen; Kathryn Gordon; Peter Classi Journal: Drugs Real World Outcomes Date: 2020-03-06